A regular panel discussion including the brightest minds in the healthcare industry. With a focus on digital health, DHR holds collaborative conversations with physicians, patients, scientists, creatives, technologists, and executives devoting their efforts to…
Continue Reading
San Francisco-based data intelligence and AI provider Databricks has raised $10 billion of expected non-dilutive financing in a Series J funding round, completing $8.6 billion to date. The new funding brings the company’s valuation…
Continue Reading
Precision medicine startup Promise Bio announced that it has emerged from stealth with an $8.3 million seed investment.Awz Ventures led the round with funding from AION Lab’s venture seeding track from AstraZeneca and Pfizer,…
Continue Reading
Sheffield-based insomnia medtech firm SleepCogni has raised £300,000, bringing its total funding to £3.9m.
The funding was raised in an Enterprise Investment Scheme pre-approved bridging round, supported by existing investors and grants.
Richard Mills, chief executive…
Lunit collabs with AstraZeneca, secures major deal in France Lunit and AstraZeneca have partnered to develop new AI-powered digital pathology solutions that predict non-small cell lung cancer (NSCLC).
Based on a media release, their collaboration aims…
Advancing precision in lung cancer diagnostics: Lunit’s collaboration with AstraZeneca aims to transform the speed and accuracy of detecting actionable mutations in NSCLC. (Courtesy of Lunit)
What You Should Know:
– Lunit, a provider of AI…
Continue Reading
AI biotech company Owkin announced a partnership with pharma giant AstraZeneca to develop an AI-powered tool designed to pre-screen for gBRCA mutations (gBRCAm) in breast cancer directly from digitized pathology slides.According to Owkin, BRCA…
Continue Reading
UK-based healthcare technology company Huma announced it secured more than $80 million in a Series D funding round, bringing its total raise to over $300 million. New and existing investors, including AstraZeneca, Leaps by Bayer,…
Continue Reading
What You Should Know:
– Mika Health, a leading developer of digital therapeutics for cancer patients, announced a collaborative initiative called “UNITE” alongside pharmaceutical giants AstraZeneca and Daiichi Sankyo.
– The strategic initiative signifies a commitment…
Continue Reading
Oncology-focused digital therapeutics company Mika Health announced a partnership with pharma companies AstraZeneca and Daiichi Sankyo for an initiative dubbed “UNITE” to provide digital therapeutics to women undergoing breast cancer treatments. Mika Health’s app gives…
Continue Reading
